Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Life Cycles Part I > Endometrial and Myometrial Neoplasia > Flashcards

Endometrial and Myometrial Neoplasia Flashcards

1
Q

Endometrial Hyperplasia Definition

A

Excessive growth of endometrial tissue (increased density of gland units) with tissue architectural alterations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Endometrial Hyperplasia Incidence

A

No firm numbers, but not rare. Occurs primarily in the later reproductive years and early post-menopause.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Endometrial Hyperplasia Cause

A

•Prolonged estrogen stimulation of the endometrium (important!)

a) Increased endogenous estrogen (obesity, polycystic ovarian disease, estrogen producing tumors of ovary)
b) Exogenous: estrogen replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Endometrial Hyperplasia Effect

A

Abnormal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Endometrial Hyperplasia Classification

A

a. Architectural: SIMPLE: Increased gland number and irregularity of glands in size, shape and spacing. COMPLEX: More densely packed glands with marked irregularity in size and shape.
b. Cytological:
- WITHOUT ATYPIA: Nuclear enlargement and size variation; chromatin evenly distributed; nucleoli not prominent; multilayering of cells may occur.
- WITH ATYPIA: Greater increase in nuclear size, pleomorphism, prominent nucleoli and coarse, irregularly distributed chromatin; loss of cellular polarity.
c. New alternative terminology: Endometrial intraepithelial neoplasia (EIN). It is roughly synonymous with “complex atypia with atypia”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Endometrial Hyperplasia Treatment

A

Remove source of excessive estrogen, curettage, progesterone suppression, hysterectomy are possible means.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Endometrial Hyperplasia Clinical Course

A
  • Immediate problem of abnormal bleeding usually can be managed satisfactorily (transfusions, hormones, etc.).
  • However, hyperplasia is an important risk factor for adenocarcinoma. Carcinoma risk ranges from 1% (simple hyperplasia w/o atypia) to 29% (complex with atypia). The presence of atypia (or EIN) is especially important, as it indicates a high risk for carcinoma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Endometrial intraepithelial neoplasia (EIN)

A
  • EIN is a more recently introduced term
  • It may be a more reproducible diagnostic entity
  • It is considered a precursor for type I endometrial carcinoma (i.e. endometrioid adenocarcinoma)
  • The diagnostic features overlap those of atypical endometrial hyperplasia (AEH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Endometrial Carcinoma

A

•Endometrial cancer is currently classified as 2 types.

  • Type I endometrial cancer is estrogen-driven with the prototype being endometrioid adenocarcinoma.
  • Type II endometrial carcinoma is non-estrogen driven with the prototype being serous carcinoma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Endometrial Carcinoma Incidence

A
  • Most common invasive cancer of female genital tract.
  • 90% of patients are older than 40 years, mainly 50-60’s.
  • Incidence is on the rise, supplanting cervical cancer as the #1 GYN cancer.

-There is both an absolute increase in endometrial cancer cases and a relative increase due to the decreasing incidence cervical cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Endometrial Carcinoma Cause

A

•Excess estrogen (see hyperplasia) is common in Type I cancer. A higher risk of endometrial carcinoma is seen in the following:

a. Obesity
b. Diabetes
c. Hypertension
d. Infertility

•There is no known cause for type II cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Endometrial Carcinoma Effect

A
  • PMB (post-menopausal bleeding) or abnormal bleeding.
  • The uterus may remain small (especially in type II tumors) or become enlarged.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Endometrial Carcinoma Morphology

A

•Diffuse or polypoid growth pattern. Spread via direct myometrial invasion to surrounding tissues. Two major categories of carcinoma are recognized:

a. Endometrioid adenocarcinoma (Type I, 85% of endometrial carcinoma) showing gland patterns that resembles normal endometrium. These are usually lower grade tumors with a relatively good prognosis.
b. Aggressive sub-types (Type II cancers): 15 to 20% of cases are serous, clear cell, and carcinosarcoma. They occur in older women (average age of 60-70’s) and are usually high grade tumors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Endometrial Carcinoma Histological Grading

A

a. FIGO Grade 1: well-defined glands with solid areas less than or equal to 5%
b. FIGO Grade 2: tumor with solid areas between 6% to 50%
c. FIGO Grade 3: tumor with solid areas more than 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Endometrial Carcinoma Nuclear Grading

A

a. Nuclear Grade 1: Nuclei of the tumor cells with minimal atypia and pleomorphism
b. Nuclear Grade 2: Nuclei of the tumor cells shows intermediate level of atypia and pleomorphism
c. Nuclear Grade 3: Nuclei of the tumor cells with dramatic atypia and pleomorphism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Endometrial Carcinoma Treatment

A
  • Treatment is usually hysterectomy and bilateral salpingo-oophorectomy.
  • Depending on the type of tumor and tumor stage, there may also be a lymph node resection, radiation therapy and/or chemotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Endometrial Carcinoma Clinical Course

A

•Prognosis depends heavily on clinical stage, histologic grade and subtype.

-For example, surgery (+/- irradiation), gives about a 95% 5-year survival in patients with stage I and grade 1 or 2 diseases. This rate drops to 50% for stage II and III endometrial carcinomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Carcinosarcoma a (mixed müllerian malignancy) Definition

A
  • Endometrial adenocarcinomas in which there is also a malignant stromal differentiation.
  • The stroma can differentiate into malignant muscle, cartilage and bone.
  • The epithelial and mesenchymal components are derived from the same tumor cells and represent two faces of the same tumor.
  • They occur in postmenopausal women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Carcinosarcoma a (mixed müllerian malignancy) Cause

A

Not related to estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Carcinosarcoma a (mixed müllerian malignancy) Effect

A

Postmenopausal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Carcinosarcoma a (mixed müllerian malignancy) Morphology

A
  • Grossly, a large mass often beyond uterus at diagnosis.
  • Histologically consist of adenocarcinoma mixed with the stromal (sarcoma) elements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Carcinosarcoma a (mixed müllerian malignancy) Clinical Course

A
  • Outcome is determined by depth of invasion and stage.
  • Highly malignant: 25-30% 5-Year Survival.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Mesenchymal Malignancies

A

•Two types, both uncommon:

  • Leiomyosarcoma
  • Endometrial Stromal Tumors

•Common features: Late reproductive years or after menopause, mass or abnormal bleeding, no estrogen connection, hematogenous spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Mesenchymal Malignancies: Leiomyosarcoma

A
  • Peak incidence 40-60 yrs.
  • Bulky, often hemorrhage mass, often with necrosis.
  • Microscopic: high mitotic rate > 5 mitoses/10HPF, pleomorphic nuclei, coagulation necrosis.
  • 40% 5-Year Survival.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Mesenchymal Malignancies: Endometrial Stromal Tumors

A

•Comprise a spectrum of tumors from benign stromal nodules (mature monotonous cells, non-invasive) to undifferentiated sarcomas with invasion into myometrium and vasculature, pleomorphic nuclei, numerous mitoses, and 50% 5 Year Survival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Benign Mesenchymal Neoplasm: Leiomyoma

A

Benign smooth muscle tumor. Not restricted to uterus but stimulated by estrogen in this site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Benign Mesenchymal Neoplasm: Leiomyoma Incidence

A

The most common tumor in women; occur in 25% women during reproductive years; multiple lesions common.

31
Q

Benign Mesenchymal Neoplasm: Leiomyoma Cause

A

Localized, heightened sensitivity to normal levels of estrogen.

32
Q

Benign Mesenchymal Neoplasm: Leiomyoma Effect

A

Asymptomatic, mass, abnormal bleeding (if submucosal), impaired fertility, dystocia (difficult labor), and rarely sarcoma.

33
Q

Benign Mesenchymal Neoplasm: Leiomyoma Morphology

A
  • Characteristic gross appearance (whorled, gray-white, sharp circumscription).
  • Location intramural > subserous > submucous.
  • Microscopic: mature smooth muscle with rare mitoses
34
Q

Benign Mesenchymal Neoplasm: Leiomyoma Treatment

A

None unless symptomatic; myomectomy, hysterectomy

35
Q

Benign Mesenchymal Neoplasm: Leiomyoma Clinical Course

A

Develop and grow in reproductive years; degenerate and shrink after menopause.

36
Q

Benign Mesenchymal Neoplasm: Leiomyoma Clinical Manifestations

A

•Clinical manifestations vary depending on the tumor locations (heavy menstruation with submucosal, asymptomatic with intramural, and torsion with subserosal tumors), size (small asymptomatic and increasing pelvic pressure in large tumors), and specific events (sharp pain in tumors with hemorrhage).

37
Q
A

Endometrial Adenocarcinoma

38
Q
A
39
Q
A
40
Q
A
41
Q
A

Endometrial Adenocarcinoma

42
Q
A
43
Q
A

Endometrial Serous Carcinoma

44
Q
A
45
Q
A
46
Q
A
47
Q
A

Endometrial Serous Carcinoma

48
Q
A
49
Q
A
50
Q
A
51
Q
A
52
Q
A
53
Q
A
54
Q
A
  • CLEAR CELL CARCINOMA (CCC)
  • Architecture: Papillary, tubulo-acinar, and solid
  • Cytoplasm: Clear or eosinophilic cytoplasm
  • Cytology: Usually high-grade, irregular nuclei, sometimes with hobnailing features
55
Q
A

Clear Cell Carcinoma

56
Q
A
  • CARCINOSARCOMA MALIGNANT MIXED MULLERIAN TUMOR (MMMT)
  • Malignant epithelium (adenocarcinoma) with malignant stromal/mesenchymal component (sarcoma)
  • Both components arise from endometrial epithelial cells (de-differentiation)
  • Age: Postmenopausal
  • Sign: Abnormal bleeding
  • Carcinoma component metastasizes more frequently than sarcomatous component
  • 25-30% 5 year survival
57
Q
A
58
Q
A
59
Q
A
60
Q
A
61
Q
A
62
Q
A

Leiomyosarcoma

63
Q
A
64
Q
A
65
Q
A
66
Q
A
67
Q
A
68
Q
A
69
Q
A
70
Q
A
71
Q
A
72
Q
A
73
Q
A
74
Q
A

Life Cycles Part I (24 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions